Nina Goodheart
Vice President and General Manager Medtronic Renal Denervation (RDN)
As Vice President and General Manager for Medtronic Renal Denervation Nina has global market
responsibility for the Medtronic renal denervation franchise.
Previous to this role Nina served as Vice President of Marketing for Medtronic CRDM, where she
had global responsibility for product marketing, market development, healthcare economics,
patient management, sales training and medical education.
Nina joined Medtronic as Vice President of CRDM Market Development in 2007, after 20+ years
providing strategic consulting to pharmaceutical and medical device companies.
Prior to Medtronic, Nina was at Sullivan & Co, a strategic consulting agency in New York, where
she worked on market development initiatives for Johnson and Johnson, as well as on Medtronic
Vascular's drug eluting stent launches.
Prior to that, Nina was Managing Director for Euro RSCG Life, a global strategic healthcare
agency in New York and New Jersey where she was responsible for US and global market
development and strategic marketing for products such as Lovenox, Plavix and Tysabri (for MS).
In addition, she has worked with Cordis, Genzyme, sanofi-aventis, BMS, Merck and AstraZeneca
on their cardiology and metabolic franchises.
Nina earned her bachelor’s from Northwestern University and her MBA from New York University.